ArticleJournal of clinical apheresis2022

Successful "on-demand" plerixafor for autologous peripheral blood stem-cells transplantation for relapsed/refractory germ cell tumors.

Andrea Corbingi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.